277 related articles for article (PubMed ID: 29073933)
1. Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis.
Abdi J; Rastgoo N; Li L; Chen W; Chang H
J Hematol Oncol; 2017 Oct; 10(1):169. PubMed ID: 29073933
[TBL] [Abstract][Full Text] [Related]
2. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
3. MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression.
Murakami Y; Kimura-Masuda K; Oda T; Matsumura I; Masuda Y; Ishihara R; Watanabe S; Kuroda Y; Kasamatsu T; Gotoh N; Takei H; Kobayashi N; Saitoh T; Murakami H; Handa H
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672841
[TBL] [Abstract][Full Text] [Related]
4. Sponges against miR-19 and miR-155 reactivate the p53-Socs1 axis in hematopoietic cancers.
Mignacca L; Saint-Germain E; Benoit A; Bourdeau V; Moro A; Ferbeyre G
Cytokine; 2016 Jun; 82():80-6. PubMed ID: 26841929
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Pichiorri F; Suh SS; Ladetto M; Kuehl M; Palumbo T; Drandi D; Taccioli C; Zanesi N; Alder H; Hagan JP; Munker R; Volinia S; Boccadoro M; Garzon R; Palumbo A; Aqeilan RI; Croce CM
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12885-90. PubMed ID: 18728182
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression.
Murray MY; Rushworth SA; Zaitseva L; Bowles KM; Macewan DJ
Cell Cycle; 2013 Jul; 12(13):2144-53. PubMed ID: 23759586
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma.
Herrero AB; Rojas EA; Misiewicz-Krzeminska I; Krzeminski P; Gutiérrez NC
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916892
[TBL] [Abstract][Full Text] [Related]
8. Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma.
Gordon MW; Yan F; Zhong X; Mazumder PB; Xu-Monette ZY; Zou D; Young KH; Ramos KS; Li Y
Mol Carcinog; 2015 Oct; 54(10):1060-9. PubMed ID: 24798859
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of the tumor suppressor p53 gene by microRNAs.
Kumar M; Lu Z; Takwi AA; Chen W; Callander NS; Ramos KS; Young KH; Li Y
Oncogene; 2011 Feb; 30(7):843-53. PubMed ID: 20935678
[TBL] [Abstract][Full Text] [Related]
10. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
Amir S; Ma AH; Shi XB; Xue L; Kung HJ; Devere White RW
PLoS One; 2013; 8(4):e61064. PubMed ID: 23585871
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a ∼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cells.
Feng M; Luo X; Gu C; Li Y; Zhu X; Fei J
RNA Biol; 2015; 12(1):82-91. PubMed ID: 25826415
[TBL] [Abstract][Full Text] [Related]
12. Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype.
Gueta K; Molotski N; Gerchikov N; Mor E; Savion S; Fein A; Toder V; Shomron N; Torchinsky A
BMC Dev Biol; 2010 Feb; 10():20. PubMed ID: 20170545
[TBL] [Abstract][Full Text] [Related]
13. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD
Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174
[TBL] [Abstract][Full Text] [Related]
14. p53 regulates CD46 expression and measles virus infection in myeloma cells.
Lok A; Descamps G; Tessoulin B; Chiron D; Eveillard M; Godon C; Le Bris Y; Vabret A; Bellanger C; Maillet L; Barillé-Nion S; Gregoire M; Fonteneau JF; Le Gouill S; Moreau P; Tangy F; Amiot M; Moreau-Aubry A; Pellat-Deceunynck C
Blood Adv; 2018 Dec; 2(23):3492-3505. PubMed ID: 30530776
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.
Boominathan L
PLoS One; 2010 May; 5(5):e10615. PubMed ID: 20485546
[TBL] [Abstract][Full Text] [Related]
16. Role of micro-RNAs in drug resistance of multiple myeloma.
Abdi J; Jian H; Chang H
Oncotarget; 2016 Sep; 7(37):60723-60735. PubMed ID: 27494872
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.
Samuel N; Wilson G; Id Said B; Pan A; Deblois G; Fischer NW; Alexandrova R; Casallo G; Paton T; Lupien M; Gariepy J; Merico D; Hudson TJ; Malkin D
Oncotarget; 2016 Aug; 7(31):49611-49622. PubMed ID: 27391063
[TBL] [Abstract][Full Text] [Related]
18. CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway.
Feng Y; Zhang L; Wu J; Khadka B; Fang Z; Gu J; Tang B; Xiao R; Pan G; Liu J
J Exp Clin Cancer Res; 2019 Feb; 38(1):54. PubMed ID: 30728056
[TBL] [Abstract][Full Text] [Related]
19. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma.
Soliman AM; Lin TS; Mahakkanukrauh P; Das S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
